The current state of CRISPR-Cas13 technology
These studies point to the promise of developing a transformative RNA targeting and manipulation tool. However, this use of CRISPR-Cas13 remains in its infancy; further investigation will be needed to take this technology into the next stage. Cox et al. tested several CRISPR-Cas13 systems and found that PspCas13b is the most efficient Cas13 protein. This study was carried out only in mammalian cells; investigation of different CRISPR-Cas13 systems and other proteins in plants might identify a Cas13 variant with more robust, specific activity for RNA manipulation in planta.
In addition, extensive biochemical and structural analyses are needed to understand the mode of action of Cas13 in different plant species, which could result in the generation of a Cas13 variant optimized for use in plants. Thus, there is a great need to further characterize and optimize RNA targeting in plants to make it highly effective, efficient and precise.
Potential uses for CRISPR-Cas13 in plants

Specific targeting of RNA
Compared to small RNAs and RNA interference, which are difficult in design and are limited by high off-target potential, CRISPR-Cas13 can be used to manipulate only the target RNA, with few or no off-target effects in eukaryotes, and multiple crRNAs can be used to eradicate a particular mRNA transcript (Figure 1a ).
Cas13 processing of pre-crRNA
The innate ability of Cas13 to process pre-crRNA into individual crRNAs [4] can facilitate simultaneous targeting of several mRNAs involved in one or multiple pathways to help fieldgrown plants cope with many simultaneous stresses or pathogens. Such gene silencing would be of great value in plant organelles in which other RNA manipulation systems do not work or are not available. Cas13 can target a single virus at multiple sites or multiple RNA viruses simultaneously (Figure 1b) . Importantly, even some of the newly evolved viral variants can still be targeted, as Cas13 tolerates single-base mismatches and cleaves targets outside of its recognition sequence [4] .
Cas13 as a diagnostic tool
Plants in the field often face mixed pathogenic infections, and identifying individual pathogens is challenging. Cas13a can be used to detect particular RNAs [7] , which could be useful for identifying the precise cause of pathogenicity, particularly at early stages of infection in the field (Figure 1c ).
Cas13 can limit pathogenicity
Plants employ programmed cell death (PCD) as a defense mechanism. Successful targeting by Cas13a in E. coli results in collateral nonspecific RNA degradation, pointing to the potential applications of PCD [3, 7] . A CRISPR-Cas13 variant with robust nonspecific RNA degradation activity can target single or multiple pathogens by triggering PCD in plant cells, thereby restricting infection ( Figure 1d ).
dCas13 as an RNA targeting platform
Targeted, noninvasive RNA modification and viral interference hold great promise, especially using an inducible CRISPR-Cas13 system to alter RNAs involved in biotic or abiotic stress or silencing an RNA virus. Like dCas9, dCas13 retains its specific RNA-binding programmability [6] . The binding of dCas13-crRNA complexes can hinder viral replication and direct specific modifications to different RNAs. For example, dCas13 can be fused to a deaminase that can convert adenosine to inosine (Inosine reads as Guanosine) to recover functional proteins, skip the virus replication machinery (Figure 1e ), or increase plant transcriptome plasticity to improve stress tolerance through customized alternative splicing (Figure 1f ). Also, epigenetic or fluorescent tags can be fused to dCas13 to direct specific epitranscriptomic changes or to visualize mRNA trafficking to specific cellular organelles (Figure 1g ). A better understanding of the extent to which CRISPR-Cas13 can cope with recombinant viral escapes is required, and careful planning is needed to avoid the potential risks of such recombinant viruses in breeding programs.
Potential limitations of using CRISPR-
Concluding Remarks
Recent findings suggest that, like CRISPR-Cas9 for DNA manipulation and engineering viral resistance [10] [11] [12] , CRISPR-Cas13 holds great promise as a robust, precise, scalable RNAtargeting platform for RNA manipulations and RNA virus targeting in plants [5, 8] . We hope that in response to the growing need for such a tool, rigorous studies will establish this system as the gold standard for RNA manipulation in plants. Such a method would provide a variety of opportunities for addressing major agricultural and food security challenges.
Box 1. The bacterial CRISPR-Cas13 system against RNA phages
Prokaryotic cells have evolved innate defense mechanisms to protect themselves against nucleic acids derived from bacteriophages and other foreign genetic elements. The CRISPR-Cas13 system functions as an "adaptive" immune system in bacteria and archaea to fend off invading RNA elements, such as RNA viruses, by recognizing the invading RNAs and mediating their subsequent degradation [3, 4] . On the first encounter with RNA phages, CRISPR-Cas13 systems acquire a short (28-30 nt) spacer sequence from the phage genome and incorporate it in their CRISPR array through an unknown mechanism. Bacterial acquired immunity occurs via three steps (see Figure   I ): (i) expression, where the CRISPR array, along with Cas13, are transcribed and Cas13 protein is produced; (ii) processing, where pre-crRNA is processed by Cas13 to form individual, short crRNAs (28-30 nt spacers and 28-36 nt Cas13 binding scaffold); and (iii) targeting or viral interference, where the invading phage RNA is cleaved by the crRNA-Cas13 complex. Upon binding to its target, Cas13 promiscuously degrades cellular RNA, leading to PCD [3, 4] . can be utilized to detect the localization of transcript/s inside plant cell [2] . Also, dCas13 fused to nuclear, mitochondrial, chloroplast, or cytoplasmic localization signals can transport mRNA to the desired cellular organelles.
